Abstract
The multidrug-resistant (MDR) Salmonella enterica serotype Newport strain that produces CMY-2 beta-lactamase (Newport MDR-AmpC) was the source of sporadic cases and outbreaks in humans in France during 2000-2005. Because this strain was not detected in food animals, it was most likely introduced into France through imported food products.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anti-Bacterial Agents / pharmacology*
-
Ceftriaxone / pharmacology*
-
Commerce
-
Drug Resistance, Bacterial* / genetics
-
Electrophoresis, Gel, Pulsed-Field
-
France / epidemiology
-
Humans
-
Meat / microbiology
-
Salmonella Infections / epidemiology*
-
Salmonella Infections / microbiology
-
Salmonella enterica / classification
-
Salmonella enterica / drug effects*
-
Salmonella enterica / enzymology
-
Salmonella enterica / genetics
-
Sequence Analysis, DNA
-
Serotyping
-
beta-Lactamases / biosynthesis*
-
beta-Lactamases / genetics
Substances
-
Anti-Bacterial Agents
-
Ceftriaxone
-
beta-lactamase CMY-2
-
beta-Lactamases